CD47 and CD68 expression in breast cancer is associated with tumor‐infiltrating lymphocytes, blood vessel invasion, detection mode, and prognosis
The Journal of Pathology: Clinical Research · 2023-05 · 9 (3) · 151-164
DOI: 10.1002/cjp2.309 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Journal of Pathology: Clinical Research, online erschienen am 04.01.2023. Verfasst von Ying Chen und 4 weiteren Autor:innen. Beteiligte Einrichtung: Centre for Cancer Biomarkers CCBIO, Department of Clinical Medicine, University of Bergen, Bergen, Norway. Hauptthemen laut MEDLINE: Breast Neoplasms, Lymphocytes, Tumor-Infiltrating. Die Arbeit wurde bisher 22-mal zitiert (Crossref) und nennt 71 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Helse Vest, Norges Forskningsråd, Sykehuset i Vestfold.
Abstract (Originalsprache)
CD47 expressed on tumor cells binds to signal regulatory protein alpha on macrophages, initiating inhibition of phagocytosis. We investigated the relationships between tumor expression of CD47 and CD68 macrophage content, subsets of tumor‐infiltrating lymphocytes (TILs), and vascular invasion in breast cancer. A population‐based series of 282 cases (200 screen detected and 82 interval patients) from the Norwegian Breast Cancer Screening Program was examined. Immunohistochemical staining for CD47 and CD68 was evaluated on tissue microarray (TMA) slides. For CD47 evaluation, a staining index was used. CD68 tumor‐associated macrophages were counted and dichotomized. TIL subsets (CD45, CD3, CD4, CD8, and FOXP3) were counted and dichotomized using immunohistochemistry on TMA slides. Vascular invasion (both lymphatic and blood vessel) was determined on whole tissue slides. High CD47 tumor cell expression or high counts of CD68 macrophages were significantly associated with elevated levels of all TIL subsets ( p < 0.02), CD163 macrophages ( p < 0.001), blood vessel invasion (CD31 positive) ( p < 0.01), and high tumor cell Ki67 ( p < 0.004). High CD47 expression was associated with ER negativity ( p < 0.001), HER2 positive status ( p = 0.03), and interval‐detected tumors ( p = 0.03). Combined high expression of CD47–CD68 was associated with a shorter recurrence‐free survival (RFS) by multivariate analysis (hazard ratio [HR]: 2.37, p = 0.018), adjusting for tumor diameter, histologic grade, lymph node status, and molecular subtype. Patients with luminal A tumors showed a shorter RFS for CD47–CD68 high cases by multivariate assessment (HR: 5.73, p = 0.004). This study demonstrates an association of concurrent high CD47 tumor cell expression and high CD68 macrophage counts with various TIL subsets, blood vessel invasion (CD31 positive), other aggressive tumor features, and interval‐presenting breast cancer. Our findings suggest a link between CD47, tumor immune response, and blood vessel invasion (CD31 positive). Combined high expression of CD47–CD68 was an independent prognostic factor associated with poor prognosis in all cases, as well as in the luminal A category.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Centre for Cancer Biomarkers CCBIO, Department of Clinical Medicine, University of Bergen, Bergen, Norway.
- Department of Pathology, Vestfold Hospital, Tønsberg, Norway.
- Department of Pathology, Oslo University Hospital, Oslo, Norway.
- Fürst Medical Laboratory, Oslo, Norway.
- Department of Surgery, Vestfold Hospital, Tønsberg, Norway.
- Department of Pathology, Haukeland University Hospital, Bergen, Norway.
ORCID-Profile: Tor Audun Klingen, Elisabeth Wik, Lars A Akslen
Förderung
- Helse Vest
- Norges Forskningsråd
- Sykehuset i Vestfold
Zitieren
APA
Chen, Y., Klingen, T. A., Aas, H., Wik, E., & Akslen, L. A. (2023). CD47 and CD68 expression in breast cancer is associated with tumor‐infiltrating lymphocytes, blood vessel invasion, detection mode, and prognosis. The Journal of Pathology: Clinical Research, 9(3), 151-164. https://doi.org/10.1002/cjp2.309
Vancouver
Chen Y, Klingen TA, Aas H, Wik E, Akslen LA. CD47 and CD68 expression in breast cancer is associated with tumor‐infiltrating lymphocytes, blood vessel invasion, detection mode, and prognosis. The Journal of Pathology: Clinical Research. 2023;9(3):151-164. doi:10.1002/cjp2.309
BibTeX
@article{Chen2023,
author = {Chen, Ying and Klingen, Tor Audun and Aas, Hans and Wik, Elisabeth and Akslen, Lars A},
title = {CD47 and CD68 expression in breast cancer is associated with tumor‐infiltrating lymphocytes, blood vessel invasion, detection mode, and prognosis},
journal = {The Journal of Pathology: Clinical Research},
year = {2023},
volume = {9},
number = {3},
pages = {151--164},
doi = {10.1002/cjp2.309}
}
EUVIMED